These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2222774)

  • 21. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor.
    Baulieu EE
    Science; 1989 Sep; 245(4924):1351-7. PubMed ID: 2781282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone-mediated immunosuppression and the maintenance of pregnancy.
    Szekeres-Bartho J; Varga P; Kinsky R; Chaouat G
    Res Immunol; 1990 Feb; 141(2):175-81. PubMed ID: 2389087
    [No Abstract]   [Full Text] [Related]  

  • 23. Direct effects of progesterone and antiprogesterone on human sperm hyperactivated motility and acrosome reaction.
    Uhler ML; Leung A; Chan SY; Wang C
    Fertil Steril; 1992 Dec; 58(6):1191-8. PubMed ID: 1459270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone inhibits 20alpha-hydroxysteroid dehydrogenase expression in the rat corpus luteum through the glucocorticoid receptor.
    Sugino N; Telleria CM; Gibori G
    Endocrinology; 1997 Oct; 138(10):4497-500. PubMed ID: 9322971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of uterine contractility by progesterone and progesterone metabolites: mediation by progesterone and gamma amino butyric acidA receptor systems.
    Putnam CD; Brann DW; Kolbeck RC; Mahesh VB
    Biol Reprod; 1991 Aug; 45(2):266-72. PubMed ID: 1664743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A progesterone-induced blocking factor corrects high resorption rates in mice treated with antiprogesterone.
    Szekeres-Bartho J; Chaouat G; Kinsky R
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1320-2. PubMed ID: 2220944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats.
    Soro A; Panarelli M; Holloway CD; Fraser R; Kenyon CJ
    J Endocrinol Invest; 1995 Dec; 18(11):833-9. PubMed ID: 8778154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of lymphocyte reactivity in pregnant women treated with the progesterone receptor inhibitor ZK 98734.
    Szekeres-Bartho J; Szabo J; Kovacs L
    Am J Reprod Immunol; 1989 Oct; 21(2):46-9. PubMed ID: 2627268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
    Lamberts SW; van Koetsveld P; Verleun T
    Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion.
    Das C; Catt KJ
    Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of bovine and ovine lymphocyte proliferation by progesterone: modulation by steroid receptor antagonists and physiological status.
    Monterroso VH; Hansen PJ
    Acta Endocrinol (Copenh); 1993 Dec; 129(6):532-5. PubMed ID: 8109187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing glucocorticoid-dependent osteogenesis in rat and chick cells in vitro by specific blockade of osteoblastic differentiation with progesterone and RU38486.
    Tenenbaum HC; Kamalia N; Sukhu B; Limeback H; McCulloch CA
    Anat Rec; 1995 Jun; 242(2):200-10. PubMed ID: 7668405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of progesterone on HLA-E gene expression in JEG-3 choriocarcinoma cell line.
    Huang Z; Hyodo H; Fujii T; Nagamatsu T; Matsumoto J; Kawana K; Yamashita T; Yasugi T; Kozuma S; Taketani Y
    Am J Reprod Immunol; 2009 Mar; 61(3):221-6. PubMed ID: 19239424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIBF: the double edged sword. Pregnancy and tumor.
    Szekeres-Bartho J; Polgar B
    Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of RU486 on progesterone and oestrogen receptor concentration in human decidua on early pregnancy.
    Zaytseva TS; Goncharova VN; Morozova MS; Astakhova TM; Manuilova IA; Pankov YA
    Hum Reprod; 1993 Aug; 8(8):1288-92. PubMed ID: 8408529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications.
    Baulieu EE
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):873-91. PubMed ID: 1778181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of progesterone and its antagonist mifepristone on progesterone receptor a expression in human umbilical vein endothelial cells.
    Toth B; Scholz C; Ochsenkuhn R; Schulze S; Kuhn C; Friese K; Jeschke U
    Gynecol Obstet Invest; 2009; 67(4):269-74. PubMed ID: 19339781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of female sexual behavior with intracerebral implants of antiprogestin RU 38486: correlation with binding to neural progestin receptors.
    Etgen AM; Barfield RJ
    Endocrinology; 1986 Oct; 119(4):1610-7. PubMed ID: 3757904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.